HRJ

official impact factor 1.46

Open Access Research

High HCV seroprevalence and HIV drug use risk behaviors among injection drug users in Pakistan

Irene Kuo1*, Salman ul-Hasan2, Noya Galai3, David L Thomas3,4, Tariq Zafar2, Mohammad A Ahmed3 and Steffanie A Strathdee5

Author Affiliations

1 Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland 21205, USA

2 Nai Zindagi, Office No. 37-38, Top floor Beverly Center, Jinnah Avenue, Blue Area, Islamabad, Pakistan

3 Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland 21205, USA

4 Division of Infectious Diseases, Johns Hopkins School of Medicine, Baltimore, Maryland 21205, USA

5 Division of International Health and Cross Cultural Medicine, University of California at San Diego, La Jolla, California 92093, USA

For all author emails, please log on.

Harm Reduction Journal 2006, 3:26 doi:10.1186/1477-7517-3-26

Published: 16 August 2006

Abstract

Introduction

HIV and HCV risk behaviors among injection drug users (IDUs) in two urban areas in Pakistan were identified.

Methods

From May to June 2003, 351 IDUs recruited in harm-reduction drop-in centers operated by a national non-governmental organization in Lahore (Punjab province) and Quetta (Balochistan province) completed an interviewer-administered survey and were tested for HIV and HCV. Multivariable logistic regression identified correlates of seropositivity, stratifying by site. All study participants provided written, informed consent.

Results

All but two were male; median age was 35 and <50% had any formal education. None were HIV-positive; HCV seroprevalence was 88%. HIV awareness was relatively high, but HCV awareness was low (19%). Injection behaviors and percutaneous exposures such as drawing blood into a syringe while injecting ('jerking'), longer duration of injection, and receiving a street barber shave were significantly associated with HCV seropositivity.

Discussion

Despite no HIV cases, overall HCV prevalence was very high, signaling the potential for a future HIV epidemic among IDUs across Pakistan. Programs to increase needle exchange, drug treatment and HIV and HCV awareness should be implemented immediately.